Globus Medical Inc
GMED· NYSE
Released Aug 5, 2020, after the close
10-Q filed Aug 5, 2020, 36 days after period end · 0001237831-20-000049
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $148.92M | $194.54M | $173.38M | $152.39M |
| Net Income | -$20.84M | $38.16M | $44.98M | $28.67M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| -$0.21 |
| $0.38 |
| $0.44 |
| $0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.